We are live on ! Find out more

678 hedge funds and large institutions have $14.5B invested in Sanofi in 2023 Q1 according to their latest regulatory filings, with 103 funds opening new positions, 268 increasing their positions, 182 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 103 | Existing positions closed: 56

54% more call options, than puts

Call options by funds: $116M | Put options by funds: $75.5M

47% more repeat investments, than reductions

Existing positions increased: 268 | Existing positions reduced: 182

14% more capital invested

Capital invested by funds: $12.7B → $14.5B (+$1.74B)

5% more funds holding

Funds holding: 643678 (+35)

0.71% more ownership

Funds ownership: 20.69%21.41% (+0.71%)

18% less funds holding in top 10

Funds holding in top 10: 1714 (-3)

Holders
678
Holders Change
+35
Holders Change %
+5.44%
% of All Funds
10.8%
Holding in Top 10
14
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-17.65%
% of All Funds
0.22%
New
103
Increased
268
Reduced
182
Closed
56
Calls
$116M
Puts
$75.5M
Net Calls
+$41M
Net Calls Change
-$38M
Name Holding Trade Value Shares
Change
Change in
Stake
Dodge & Cox
1
Dodge & Cox
California
$4.49B -$81.3M -1,671,748 -2%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$1.27B +$165M +3,387,606 +17%
Boston Partners
3
Boston Partners
Massachusetts
$976M -$14.6M -300,961 -2%
Fisher Asset Management
4
Fisher Asset Management
Washington
$727M -$20.9M -430,041 -3%
Bank of America
5
Bank of America
North Carolina
$578M +$75M +1,541,832 +17%
BlackRock
6
BlackRock
New York
$547M +$12.1M +249,619 +3%
Morgan Stanley
7
Morgan Stanley
New York
$429M +$7.66M +157,574 +2%
Invesco
8
Invesco
Georgia
$356M +$20M +410,699 +7%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$341M +$32.5M +667,195 +12%
CCM
10
Camber Capital Management
Massachusetts
$299M -$73M -1,500,000 -21%
N
11
Nuveen
North Carolina
$166M +$48M +987,166 +48%
Goldman Sachs
12
Goldman Sachs
New York
$144M +$6.58M +135,353 +5%
Adage Capital Partners
13
Adage Capital Partners
Massachusetts
$143M +$1.74M +35,700 +1%
Hotchkis & Wiley Capital Management
14
Hotchkis & Wiley Capital Management
California
$129M -$4.29M -88,250 -4%
Arrowstreet Capital
15
Arrowstreet Capital
Massachusetts
$127M -$53M -1,089,377 -32%
Wells Fargo
16
Wells Fargo
California
$127M +$33.3M +684,637 +42%
Millennium Management
17
Millennium Management
New York
$124M -$65.6M -1,349,580 -37%
Federated Hermes
18
Federated Hermes
Pennsylvania
$114M +$90.3M +1,856,263 +756%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$112M +$16.9M +347,944 +20%
T. Rowe Price Associates
20
T. Rowe Price Associates
Maryland
$111M -$40.5M -833,389 -29%
EIC
21
Equity Investment Corp
Georgia
$109M +$3.94M +81,015 +4%
Envestnet Asset Management
22
Envestnet Asset Management
Illinois
$108M +$212M +4,364,665 +316%
Natixis Advisors
23
Natixis Advisors
Massachusetts
$108M +$14.6M +299,652 +18%
JP Morgan Chase
24
JP Morgan Chase
New York
$103M -$77.4M -1,591,811 -46%
RJA
25
Raymond James & Associates
Florida
$95.6M +$38.9M +800,615 +84%

SNY Hedge Fund Activity: Q1 2023 in Review

678 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q1 2023, worth a combined $14.5B — up 14% from $12.7B a quarter earlier.

Buyers outnumbered sellers: 103 funds opened new SNY positions and 56 closed out — a net gain of 47 holders — while 268 added to existing stakes and 182 trimmed.

The largest buyer was Envestnet Asset Management, adding an estimated $212M. The largest seller was MUFG Securities EMEA, exiting entirely with an estimated $96.3M sold.

  • 678 institutional investors held Sanofi (SNY) as of Q1 2023, up from 643 in Q4 2022.
  • Funds reported $14.5B of Sanofi stock for Q1 2023, up 14% quarter-over-quarter.
  • 103 funds opened new Sanofi positions in Q1 2023 and 56 closed out, a net change of +47 holders.
  • The largest Sanofi buyer in Q1 2023 was Envestnet Asset Management, an estimated $212M added.
  • The largest Sanofi seller in Q1 2023 was MUFG Securities EMEA, an estimated $96.3M sold.

Based on aggregated 13F filings for Q1 2023.